Salofalk

Medicinal product

(Invented) name

Salofalk

Active substance (s)

Mesalazinas

Strength

500 mg

Pharmaceutical form

žvakutės

Route (s) of administration

vartoti į tiesiąją žarną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07EC02, Mesalazine

Marketing authorisation holder

Dr.Falk Pharma GmbH, Vokietija

Date of authorisation

1995-02-15

Date of renewal

2010-09-08

Documents

0445 Salofalk 500mg zvakutes PCS PL 2025 01 28.docx

0445 Pakuotės lapelis zvakutes 2025 01 28.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Žvakutėje yra	1 vnt.
Mesalazinas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
17394	1735	1001735	dvisluoksnė juostelė	N30		Receptinis	LT/1/95/0445/004	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2010-09-08	Perregistruotas
1995-02-15	Registruotas